Chromosomal instability is associated with paradoxical cGAS upregulation and impaired STING signaling shaping the immune microenvironment in glioblastoma

Clicks: 1
ID: 320546
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #85 of 104 articles by views in Neuro-Oncology Advances

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Glioblastoma (GBM) is characterized by pronounced chromosomal instability (CIN), which can activate the cyclic GMP–AMP synthase–stimulator of interferon genes (cGAS–STING) pathway and promote anti-tumor immunity. How CIN engages cGAS–STING in immunologically “cold” GBM and its relation to clinical outcomes remain unclear. Methods CIN was quantified in 74 tissue cores from 34 patients with isocitrate dehydrogenase-wildtype GBM by chromosome 7/10 fluorescence in situ hybridization; aneuploidy score (AS) and heterogeneity score were derived. Immunohistochemistry assessed cGAS, STING, phosphorylated IRF3 (p-IRF3), and immune markers (CD3, CD4, CD8, CD163, IBA-1). Polyploid giant cancer cells (PGCCs) were identified using hematoxylin and eosin staining. EGFR, PDGFRA, CDKN2A, and PTEN copy-number alterations were assessed by multiplex ligation-dependent probe amplification. The Cancer Genome Atlas (TCGA)-GBM cohort served as an independent dataset. Results High AS (≥1.36) was associated with longer overall survival (22.7 vs. 16.0 months, p = 0.039). cGAS expression correlated positively with AS (p = 0.019), consistent with cGAS engagement in highly aneuploid tumors. Conversely, STING was rarely expressed in tumor cells, restricted to stromal and vascular compartments, without accompanying immune infiltration. STING-positive regions were enriched for PGCCs (p = 0.045), suggesting stress adaptation rather than immune activation. p-IRF3 modestly correlated with AS (Spearman r = 0.39, p = 0.0006) and was reduced in EGFR-amplified or PTEN-loss cores (p = 0.003 each). In TCGA-GBM, surrogate AS stratification revealed a biphasic survival pattern consistent with our findings. Conclusions CIN was associated with cGAS upregulation but not functional STING-mediated immunity in GBM, suggesting that CIN-associated intrinsic stress adaptation may contribute to immunotherapy resistance in GBM.
Reference Key
openalex_W7167919573 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Hidenobu Yoshitake, Tetsuya Negoto, Mayuko Moritsubo, Takuya Furuta, Minji Jo, Toru Hirota, Kiyohiko Sakata, Hideo Nakamura, Motohiro Morioka
Journal Neuro-Oncology Advances
Year 2026
DOI
10.1093/noajnl/vdag179
URL
https://doi.org/10.1093/noajnl/vdag179
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.